Hydralazine Hydrochloride
Product Images NDC 17478-934

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 17478-934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hyd0a 0011 01

Chemical structure of Hydralazine Hydrochloride, showing the molecular arrangement of the hydralazine moiety combined with a hydrochloride (HCl) component.*

FDA Label Image

Hyd0a 0011 02

Hydralazine Hydrochloride Injection, USP 20 mg/mL single-dose vial label by Akorn. The label indicates a 1 mL vial for intramuscular or intravenous use, with storage instructions and manufacturer details. Includes NDC 17478-934-01 and barcode.*

FDA Label Image

Hyd0a 0011 03

Hydralazine Hydrochloride Injection, USP 20 mg/mL single-dose vial carton. The label states it is for intramuscular or intravenous use and contains 10 vials of 1 mL each. Manufactured by Akorn, the carton lists inactive ingredients, preservatives, storage instructions, and includes the NDC 17478-934-10 barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.